|
CMAS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.917700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.497900E-02 |
| Normal-vs-Stage2 |
2.746600E-01 |
| Normal-vs-Stage3 |
2.480400E-02 |
| Normal-vs-Stage4 |
1.270140E-02 |
| Stage1-vs-Stage2 |
8.940400E-01 |
| Stage1-vs-Stage3 |
3.250400E-01 |
| Stage1-vs-Stage4 |
2.338000E-01 |
| Stage2-vs-Stage3 |
4.247400E-01 |
| Stage2-vs-Stage4 |
2.888600E-01 |
| Stage3-vs-Stage4 |
6.633200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.419680E-02 |
| Normal-vs-AfricanAmerican |
7.604600E-01 |
| Normal-vs-Asian |
1.918430E-01 |
| Caucasian-vs-AfricanAmerican |
2.481200E-01 |
| Caucasian-vs-Asian |
5.656600E-01 |
| AfricanAmerican-vs-Asian |
5.151400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.367700E-02 |
| Normal-vs-Female |
4.725800E-02 |
| Male-vs-Female |
5.538200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.010600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.459800E-02 |
| Normal-vs-Age(61-80Yrs) |
9.003900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.522000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.076800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.054000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.455200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.288400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.689800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.991000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.648200E-01 |
| Classical-VS-Follicular |
9.328200E-01 |
| Classical-VS-Other |
8.578600E-01 |
| Classical-VS-Normal |
1.327640E-01 |
| Tall-VS-Follicular |
3.086800E-01 |
| Tall-VS-Other |
7.130000E-01 |
| Tall-VS-Normal |
4.021900E-02 |
| Follicular-VS-Other |
8.728200E-01 |
| Follicular-VS-Normal |
2.642600E-01 |
| Other-VS-Normal |
4.274800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.896200E-02 |
| Normal-vs-N1 |
3.163600E-03 |
| N0-vs-N1 |
2.069600E-01 |
|
|
